Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Head & Neck|June 18, 2026
Metastatic Lymph Node Status Is Associated With Progression-Free Survival in Oral Cavity Squamous Cell Carcinoma Treated With PembrolizumabAngeline A Truong, Savinnie Ho, Minna K I Apostolova, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Commensal myeloid crosstalk in neonatal skin regulates long-term cutaneous type 17 inflammationMiqdad O Dhariwala, Andrea M DeRogatis, Joy N Okoro, et al.
Science (New York, N.Y.)|December 15, 2022
Synthetic cytokine circuits that drive T cells into immune-excluded tumorsGreg M Allen, Nicholas W Frankel, Nishith R Reddy, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2022
A conserved immune trajectory of recovery in hospitalized COVID-19 patientsCassandra E Burnett, Trine Line Hauge Okholm, Iliana Tenvooren, et al.
Immunity|July 2, 2022
Mass cytometry reveals a conserved immune trajectory of recovery in hospitalized COVID-19 patientsCassandra E Burnett, Trine Line Hauge Okholm, Iliana Tenvooren, et al.
Clinical Colorectal Cancer|March 13, 2026
Phase II Study of Pembrolizumab Plus Capecitabine and Bevacizumab for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal CancerAndrea Bocobo, Julia Whitman, Bridget P Keenan, et al.
Cell|June 5, 2020
Intratumoral CD4<sup>+</sup> T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder CancerDavid Y Oh, Serena S Kwek, Siddharth S Raju, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Coordinated variation in the immune systems and microbiomes of healthy humans is linked to tonic interferon statesJoel Babdor, Ravi K Patel, Brittany Davidson, et al.
Nature Medicine|January 17, 2017
Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological statesDavid Furman, Junlei Chang, Lydia Lartigue, et al.
Journal for Immunotherapy of Cancer|January 17, 2024
Lower frequencies of circulating suppressive regulatory T cells and higher frequencies of CD4<sup>+</sup> naïve T cells at baseline are associated with severe immune-related adverse events in immune checkpoint inhibitor-treated melanomaMagdalena Kovacsovics-Bankowski, Johanna M Sweere, Connor P Healy, et al.
Pageof 15